WOODSIDE, Calif., March 02, 2017 -- GSV Capital Corp. (“GSV Capital”) (Nasdaq:GSVC) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2016 after the close of the U.S. market on Monday, March 13, 2017.
Management will hold a conference call and webcast for investors on the same day at 2:00 p.m. PT (5:00 p.m. ET). The conference call number for U.S. participants is 877-852-6543, and the conference call number for participants outside the U.S. is 719-325-4839. The conference ID number for both call numbers is 8092483. Additionally, interested parties can listen to a live webcast of the call from the "Investors" section of GSV Capital’s website at http://investors.gsvcap.com/. An archived replay of the webcast will also be available for 12 months following the live presentation.
A replay of the conference call may be accessed until 5:00 p.m. PT (8:00 p.m. ET) on March 20, 2017 by dialing 888-203-1112 (U.S.) or 1 719-457-0820 (International) and using conference ID number 8092483.
About GSV Capital Corp.
GSV Capital Corp. (GSVC) is a publicly traded investment fund that seeks to invest in high-growth, venture-backed private companies. Led by industry veteran Michael Moe, the fund seeks to create a portfolio of high-growth emerging private companies via a repeatable and disciplined investment approach, as well as to provide investors with access to such companies through its publicly traded common stock. GSV Capital is headquartered in Woodside, CA. www.gsvcap.com
Follow GSV Capital on Twitter: @gsvcap
The GSV Capital Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=12750
Contact GSV Capital Corp. (650) 235-4769 [email protected]


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 



